Immix Biopharma
IMMX
11 hedge funds and large institutions have $5.47M invested in Immix Biopharma in 2021 Q4 according to their latest regulatory filings, with 11 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.
20.3% more ownership
Funds ownership: 0% → 20.3% (+20%)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
M
Murchinson
Toronto,
Ontario, Canada
|
+$2.38M |
| 2 |
ACM
Altium Capital Management
New York
|
+$419K |
| 3 |
UBS Group
Zurich,
Switzerland
|
+$112K |
| 4 |
EVC
Eidelman Virant Capital
Saint Louis,
Missouri
|
+$102K |
| 5 |
Citadel Advisors
Miami,
Florida
|
+$90.6K |
Top Sellers
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
M
1
Murchinson
Toronto,
Ontario, Canada
| $2.48M | +$2.38M | +695,600 | New |
|
|
LCM
2
Lynwood Capital Management
Toronto,
Ontario, Canada
| $2.01M | +$1.93M | +565,297 | New |
|
|
ACM
3
Altium Capital Management
New York
| $436K | +$419K | +122,388 | New |
|
|
4
UBS Group
Zurich,
Switzerland
| $116K | +$112K | +32,649 | New |
|
|
EVC
5
Eidelman Virant Capital
Saint Louis,
Missouri
| $103K | +$102K | +29,856 | New |
|
|
6
Citadel Advisors
Miami,
Florida
| $94K | +$90.6K | +26,474 | New |
|
7
Millennium Management
New York
| $73K | +$70K | +20,470 | New |
|
|
PAM
8
PVG Asset Management
Golden,
Colorado
| $71.2K | +$68.4K | +20,000 | New |
|
|
TSS
9
Two Sigma Securities
New York
| $47K | +$45.1K | +13,173 | New |
|
|
CCM
10
Context Capital Management
Lajolla,
California
| $41K | +$39.5K | +11,532 | New |
|
|
CS
11
Clear Street
New York
| $4K | +$3.42K | +1,000 | New |
|
IMMX Hedge Fund Activity: Q4 2021 in Review
11 of the 6,499 institutional investors tracked by Wall St. Rank reported a position in Immix Biopharma (IMMX) for Q4 2021, worth a combined $5.47M.
Buyers outnumbered sellers: 11 funds opened new IMMX positions and 0 closed out — a net gain of 11 holders — while 0 added to existing stakes and 0 trimmed.
The largest buyer was Murchinson, opening a new position worth an estimated $2.38M.
- 11 institutional investors held Immix Biopharma (IMMX) as of Q4 2021, up from 0 in Q3 2021.
- Funds reported $5.47M of Immix Biopharma stock for Q4 2021.
- 11 funds opened new Immix Biopharma positions in Q4 2021 and 0 closed out, a net change of +11 holders.
- The largest Immix Biopharma buyer in Q4 2021 was Murchinson, an estimated $2.38M added.
Based on aggregated 13F filings for Q4 2021.